Quanterix Q2 revenue up 11% to $34.4M; net loss widens to $9.5M; cuts FY2024 revenue guidance

Quanterix Corp

2024-Q2 EPS reported -$0.51 revenue$66,447,000

Revenue $34.4M (+10.8% YoY); GAAP gross margin 58.3% vs 61.7% prior year.
Net loss $9.5M, up $3.4M from prior year; cash usage $5.1M in quarter.
Revised FY2024 revenue guidance to $134M-$138M from $139M-$144M due to constrained capital environment.
Cash usage for 2024 now expected at higher end of $25M-$30M range.
New Alzheimer's diagnostic partnerships with Mt. Sinai, Banner Health, UCSF, and KingMed Diagnostics.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.